Journal Guide

Aims and Scope: ALTEX, edited by the Swiss Society ALTEX Edition is the official journal of CAAT (Center for Alternatives to Animal Testing, Johns Hopkins University, Baltimore, USA), EUSAAT (European Society for Alternatives to Animal testing) and T4 (transatlantic think tank of toxicology, Baltimore, Konstanz, Utrecht). ALTEX, issued by the Swiss society ALTEX Edition, is the official journal of ASCCT, the American Society for Cellular and Computational Toxicology, CAAT, the Center for Alternatives to Animal Testing at the Johns Hopkins University Baltimore, USA, CAAT-Europe the Center for Alternatives to Animal Testing Europe at the University of Konstanz, Germany, EUSAAT, the European Society for Alternatives to Animal Testing, t4, the transatlantic think tank of toxicology (Baltimore, Utrecht, Konstanz) and the Doerenkamp chairs in Germany, India, The Netherlands, Switzerland and USA. ALTEX publishes original articles, short communications, reviews, as well as news and comments, meeting reports and book reviews. ALTEX is devoted to the publication of research on the development and promotion of alternatives to animal experiments according to the 3R concept of Russell and Burch: Replace, Reduce, and Refine. Animal experiments are defined as all experimental procedures involving the use of animals in testing, research and education or to obtain tissues, organs, and other animal-derived products which may cause pain or distress to animals. ALTEX further publishes manuscripts on the bioethics of the complex relationship between humans and animals. Articles published in ALTEX must express a basic concern for the dignity of living creatures and the recognition of animals as our partners. All articles are judged according to stringent scientific standards. Manuscripts submitted to , ALTEX are evaluated by two reviewers. The evaluation takes into account the scientific merit of a manuscript and its contribution to animal welfare and the 3R principle. Please visit www.altex-edition.org for further information. Copyright: Society ALTEX Edition, Kuesnacht, Zurich

Chaque mois, la revue Actualités pharmaceutiques vous propose de retrouver toutes les informations indispensables pour votre pratique quotidienne grâce à ses rubriques:Actualités Toute l'actualité médicale, pharmaceutique et professionnelle de l'équipe officinale.FormationDes informations rigoureuses et de qualité indispensables pour la formation continue des pharmaciens : mises au point sur des pathologies, dossier de fond de haut niveau pour faire le point sur une classe thérapeutique.PratiqueDes rubriques régulières couvrant l'ensemble des fonctions de la pratique quotidienne officinale (conseil, dispensation, pharmacovigilance, prévention, substitution, vétérinaire) et des domaines thérapeutiques (allopathie, phytothérapie, homéopathie, dermocosmétologie...).GuideUn mémo riche en informations utiles pour la gestion de l'officine : nouveaux produits, législation, marketing, merchandising, livres, agenda, agencement, gestion et informatique.

The focus of Addiction Biology is on neuroscience contributions, which aim at advancing our understanding regarding aspects on the action of drugs of abuse and addictive processes. Papers are accepted whose content is geared towards behavioral, molecular, genetic, biochemical, neuro-biological and pharmacological fields of animal experimentation and clinical research.

The American Journal of Health-System Pharmacy (AJHP) is the official publication of the American Society of Health-System Pharmacists (ASHP). It publishes peer reviewed scientific papers on contemporary drug therapy and pharmacy practice innovations in hospitals and health systems. With a circulation of nearly 40,000, AJHP is the most widely recognized and respected clinical pharmacy journal in the world.Articles in AJHP are abstracted and indexed in PubMed and many other scientific databases. The views expressed by authors of contributions in AJHP do not necessarily reflect the policy of ASHP or the institution with which the author is affiliated, unless this is clearly specified. Policy statements and official positions of ASHP are clearly labeled as such. Authors, reviewers, editorial board members, contributing editors, and AJHP editors are required to declare potential conflicts of interest regarding manuscripts submitted for publication.

The American Journal of Therapeutics is an indispensable resource for all prescribing physicians who want to access pharmacological developments in cardiology, infectious disease, oncology, anesthesiology, nephrology, toxicology and psychotropics without having to sift through stacks of medical journals. AJT features original articles on the latest therapeutic approaches as well as critical articles on the drug approval process, therapeutic reviews covering pharmacokinetics, regulatory affairs, pediatric clinical pharmacology, hypertension, metabolism, and drug delivery systems. Plus, clinical pharmacology and clinical therapeutics conferences update physicians and physicians-in-training on treating disease.

This journal proposes a scientific information validated and indexed to be informed about the last research works in all the domains interesting the pharmacy.The original works, general reviews, the focusing, the brief notes, subjected by the best academics and the professionals, propose a synthetic approach of the last progress accomplished in the concerned sectors. The thematic Sessions and the ¿ life of the Academy ¿ resume the communications which, presented in front of the national Academy of pharmacy, are in the heart of the current events. The analyses of the theses and the works, the comments of articles and the questions of current events offer an alive and interactive outline of the last news to keep posted real time about the evolution of the knowledge useful for the pharmacist. This journal is the official organ of expression of the Academie Nationale de Pharmacie - French National Academy of Pharmacy.

The Annual Review of Pharmacology and Toxicology, in publication since 1961, covers the significant developments in the fields of pharmacology and toxicology, including receptors, transporters, enzymes, and chemical agents; drug development science; systems such as the immune system, central and autonomic nervous systems, gastrointestinal system, cardiovascular system, endocrine system, and pulmonary system; and special topics.

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.

Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy.

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new anti-inflammatory & anti-allergy agents.

Antimicrobial Agents and Chemotherapy® features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy. The journal also publishes studies involving animal models, pharmacological characterization, and clinical trials.

Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses:antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action;new or improved vaccines against viral infections of humans and animals;assessments of drug and vaccine safety;evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures;identification and validation of new drug targets;laboratory animal models of viral diseases;pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.Antiviral Research is an official publication of the International Society for Antiviral Research (http://www.isar-icar.com).Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Antiviral Therapy (an official publication of the International Society of Antiviral Research) is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases (2009 ISI impact factor: 4.32).The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy. It features editorials, original research papers, specially commissioned review articles, letters and book reviews. The journal is aimed at physicians and specialists interested in clinical and basic research.

Apoptosis is an international peer-reviewed journal devoted to the rapid publication of innovative basic and clinically-oriented investigations into programmed cell death. It aims to stimulate research on the basis of mechanisms of apoptosis and on its role in various human disease processes including: cancer, autoimmune disease, viral infection, AIDS, cardiovascular disease, neurodegenerative disorders, osteoporosis and ageing. The editors intend to encourage the development of clinical therapies against apoptosis-related diseases.

Asian Journal of Pharmaceutical Sciences (AJPS) is the official journal of Asian Federation for Pharmaceutical Sciences(AFPS), which provides the forum for reporting innovations, production methods, technologies, initiatives and the application of scientific knowledge to all aspects of pharmaceutics, including controlled drug release systems, drug targeting, physical pharmacy, pharmacodynamics, pharmacokinetics, pharmacogenomics, biopharmaceutics, drug and prodrug design, pharmaceutical analysis, drug stability, quality control, pharmaceutical engineering and material sciences.